L'hôpital Pierre-Wertheimer est un hôpital situé à Bron dans la Métropole de Lyon, dans le groupement hospitalier Est.

During the past decade, Hopital Neurologique Pierre Wertheimer conducted 100 clinical trials. In the 10-year time frame, 100 clinical trials started and 29 clinical trials were completed, i.e. on average, 29% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 21 clinical trials were completed. i.e. 46.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Neurologique Pierre Wertheimer" #1 sponsor was "Hoffmann-La Roche" with 25 trials, followed by "Hospices Civils de Lyon" with 18 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 6 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored and "Ipsen" with 4 trials sponsored. Other sponsors include 87 different institutions and companies that sponsored additional 67 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Neurologique Pierre Wertheimer" #1 collaborator was "Alzheimer's Association" with 4 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator, "National Institute on Aging (NIA)" with 4 trials as a collaborator, "Accelerating Medicines Partnership (AMP)" with 3 trials as a collaborator and "Hoffmann-La Roche" with 3 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Neurologique Pierre Wertheimer" are "Multiple Sclerosis" (12 trials), "Parkinson's Disease" (11 trials), "Alzheimer Disease" (10 trials), "Alzheimer's Disease" (10 trials) and "Amyotrophic Lateral Sclerosis" (7 trials). Many other conditions were trialed in "Hopital Neurologique Pierre Wertheimer" in a lesser frequency.

Most popular intervention types in "Hopital Neurologique Pierre Wertheimer" are "Drug" (89 trials), "Other" (21 trials), "Biological" (17 trials), "Device" (14 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (38 trials), "Ocrelizumab" (11 trials), "Gantenerumab" (8 trials), "Temozolomide" (7 trials) and "Bevacizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Neurologique Pierre Wertheimer" are 147 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hopital Neurologique Pierre Wertheimer". 3 are not yet recruiting, 32 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 64 completed trials in Hopital Neurologique Pierre Wertheimer, 1 suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Neurologique Pierre Wertheimer, 2 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 62 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 16 trials that are defined as “Not Applicable".

Hopital Neurologique Pierre Wertheimer has several departments that took part in Clinical trials: "Hospices Civils de Lyon Hôpital Neurologique Pierre Wertheimer Cellule Mutualisée de Recherche Clinique (CMRC)" - 4 trials